Featured Research

from universities, journals, and other organizations

Fibroblasts contribute to melanoma tumor growth

Date:
January 9, 2012
Source:
H. Lee Moffitt Cancer Center & Research Institute
Summary:
Fibroblasts, cells that play a role in the structural framework of tissues, play an apparent role in melanoma tumor growth. Fibroblasts also contribute to melanoma drug resistance and may also facilitate the "flare" response when a tumor's metabolism is enhanced following a patient being removed from a targeted therapy, said researchers.

Fibroblasts, cells that play a role in the structural framework of tissues, play an apparent role in melanoma tumor growth. Fibroblasts also contribute to melanoma drug resistance and may also facilitate the "flare" response when a tumor's metabolism is enhanced following a patient being removed from a targeted therapy, said researchers at Moffitt Cancer Center in Tampa, Fla.

Alexander R. Anderson, Ph.D., co-director of Integrative Mathematical Oncology at Moffitt, and Moffitt Comprehensive Melanoma Research Center member Keiran S. Smalley, Ph.D., along with colleagues from the Wistar Institute in Philadelphia, investigated the role of fibroblasts in melanoma progression and published their findings in a recent issue of Molecular Pharmaceutics.

"A role for fibroblasts in cancer progression has long been suspected," explained Anderson, who works with mathematical models of cancer to investigate tumor cell- microenvironment interactions. "In this study, we used an integrated mathematical and experimental approach to investigate whether melanoma cells recruit, activate and stimulate fibroblasts to deposit certain proteins known to be pro-survival for melanoma cells."

Fibroblasts are the most common of connective tissues, and they function to synthesize the "extra cellular matrix" of cells and collagen, the structural framework -- also called "stroma" -- for tissues.

The researchers knew that fibroblasts were drawn to cancer cells and that they became activated by cancer cells. They also knew that different cancer cell lines have varying capabilities for recruiting and stimulating fibroblasts. An expectation has been that aggressive cancers stimulate fibroblasts more than do less aggressive cancers.

When they investigated the relationship between fibroblasts and tumors using mathematical models, the research team came up with some unexpected findings.

Anderson and Smalley expected the fibroblast-derived "extra cellular matrix" that supports the tumor structure to have "direct effects on tumor behavior." However, once they ran their theoretical models they came up with a number of unexpected conclusions with potentially far-reaching implications about drug resistance and tumor growth.

"Our finding that the fibroblast population might facilitate the "flare response" -- a period during which a tumor has enhanced metabolism and increases it progression trajectory after patients are removed from targeted therapy -- was a surprise," said Smalley, whose research aims at developing new therapies for melanoma and getting them into clinical practice.

The researchers knew that a targeted therapy would kill only the tumor population, not the fibroblasts in the tumor structure. However, the finding that fibroblasts contribute to melanoma drug resistance was unexpected.

"Targeted therapies may actually hasten tumor progression when they are stopped due to resistance to the targeted drug," said Smalley. "We found in our models that fibroblasts appear to facilitate the flare response after targeted therapy ends."

Their conclusions about the relationship between fibroblasts and cancer tumors were not predicted or expected, but revealed though the use of mathematical models.

"If these conclusions are confirmed experimentally, we may gain important new insights into how drug resistance can be managed clinically," concluded Anderson.


Story Source:

The above story is based on materials provided by H. Lee Moffitt Cancer Center & Research Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Edward H. Flach, Vito W. Rebecca, Meenhard Herlyn, Keiran S. M. Smalley, Alexander R. A. Anderson. Fibroblasts Contribute to Melanoma Tumor Growth and Drug Resistance. Molecular Pharmaceutics, 2011; 8 (6): 2039 DOI: 10.1021/mp200421k

Cite This Page:

H. Lee Moffitt Cancer Center & Research Institute. "Fibroblasts contribute to melanoma tumor growth." ScienceDaily. ScienceDaily, 9 January 2012. <www.sciencedaily.com/releases/2012/01/120105131643.htm>.
H. Lee Moffitt Cancer Center & Research Institute. (2012, January 9). Fibroblasts contribute to melanoma tumor growth. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2012/01/120105131643.htm
H. Lee Moffitt Cancer Center & Research Institute. "Fibroblasts contribute to melanoma tumor growth." ScienceDaily. www.sciencedaily.com/releases/2012/01/120105131643.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins